Loading clinical trials...
Loading clinical trials...
An Open-Label Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia
Conditions
Interventions
Alirocumab SAR236553 (REGN727)
Atorvastatin
+10 more
Locations
10
Brazil
Investigational Site Number 0760001
São Paulo, Brazil
Investigational Site Number 1240001
Québec, Canada
Investigational Site Number 2080001
Viborg, Denmark
Investigational Site Number 4840006
Oaxaca City, Mexico
Investigational Site Number 5280001
Amsterdam, Netherlands
Investigational Site Number 6430002
Kemerovo, Russia
Start Date
August 31, 2018
Primary Completion Date
February 17, 2020
Completion Date
February 17, 2020
Last Updated
December 29, 2020
NCT07058077
NCT06555120
NCT06287177
NCT00353782
NCT06556745
NCT06314919
Lead Sponsor
Sanofi
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions